Amplify ETFs Achieves Landmark $10 Billion in Assets Under Management
MWN-AI** Summary
Amplify ETFs, a prominent innovator in the exchange-traded fund (ETF) space, has recently reached a significant milestone by surpassing $10 billion in assets under management, marking an important achievement in its eight-year history. This accomplishment places Amplify among the top 30 ETF sponsors by revenue, according to VettaFi. CEO Christian Magoon highlighted the importance of this milestone, expressing gratitude for the trust investors and partners have placed in Amplify’s unique strategies, which inspires the firm to keep innovating.
The Amplify CWP Enhanced Dividend Income ETF (DIVO) emerged as the company's largest fund, experiencing robust inflows in 2024. Following it were the Amplify Junior Silver Miners ETF (SILJ) and Amplify High Income ETF (YYY), benefitting from favorable market conditions. Throughout the year, the company launched five new ETFs in various categories, emphasizing its commitment to catering to diverse investor needs. Some of these innovative products include the Amplify Bloomberg AI Value Chain ETF (AIVC) and the Amplify Weight Loss Drug & Treatment ETF (THNR).
The firm has prioritized strategic partnerships, collaborating with industry leaders like Bloomberg and VettaFi to enhance its offerings. Additionally, Amplify’s workforce expanded by 33% to bolster distribution capabilities, while earning recognition in the form of industry awards, including Digital Assets ETF of the Year for the Amplify Transformational Data Sharing ETF (BLOK).
With a focus on continuous innovation and collaboration, Amplify ETFs aims to deliver impactful investment solutions to meet evolving investor demands, ensuring that it remains a competitive force in the ETF market.
MWN-AI** Analysis
Amplify ETFs' recent achievement of surpassing $10 billion in assets under management (AUM) is a significant milestone that reflects the growing confidence of investors in its innovative ETF offerings. This success positions Amplify among the top ETF sponsors by revenue, indicating strong market positioning and trust built over eight years. Given the current market landscape, investors considering Amplify ETFs might find several insights beneficial.
The Amplify CWP Enhanced Dividend Income ETF (DIVO) stands out as the firm’s largest fund, demonstrating its ability to attract substantial investor interest. Its focus on dividend income is particularly relevant in a fluctuating interest rate environment, as income-seeking investors may increasingly turn to such funds for stability and yield. Additionally, funds like the Amplify Junior Silver Miners ETF (SILJ) and Amplify High Income ETF (YYY) have also seen robust inflows, highlighting a diversified offering that caters to different investor strategies.
The launch of five new ETFs, including thematic funds such as the Amplify Bloomberg AI Value Chain ETF (AIVC) and the Amplify Weight Loss Drug & Treatment ETF (THNR), showcases Amplify's adaptability to global trends and investor demands. The emphasis on both thematic and core strategies suggests potential growth avenues for investors interested in niche sectors and higher volatility plays.
Furthermore, Amplify's commitment to deepened partnerships with industry leaders like Bloomberg and Samsung Asset Management enhances its capabilities to offer novel, research-backed investment solutions. This is crucial for investors seeking an edge in market competitiveness.
Overall, while the performance of Amplify ETFs has been commendable, potential investors should evaluate market conditions, specific fund objectives, and risks associated with new ETF strategies. The continuing evolution of Amplify ETFs reinforces the firm’s innovative spirit, making it a compelling candidate for investors aiming for diversified exposure in both traditional and emerging sectors.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
CHICAGO, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs, a leading provider of innovative exchange-traded funds, proudly announces a significant milestone in its eight-year journey: surpassing $10 billion in assets under management. The achievement positions Amplify ETFs among the top 30 ETF sponsors by revenue, as reported by VettaFi. 1
“Surpassing $10 billion in assets under management is an inspiring milestone for our organization,” said Christian Magoon, CEO of Amplify ETFs. “We're grateful for the trust and confidence investors, advisors and partners place in our innovative strategies. It fuels our ambition to continue pushing boundaries and delivering ETFs that resonate with today’s investors.”
Amplify ETFs’ largest fund, the Amplify CWP Enhanced Dividend Income ETF (DIVO), generated strong flows in 2024, followed by the Amplify Junior Silver Miners ETF (SILJ) and Amplify High Income ETF (YYY). Additionally, many of Amplify ETFs' strategies benefited from strong market performance over the calendar year.
In 2024, Amplify ETFs launched five new ETFs across its income, thematic and core categories, reflecting its dedication to addressing diverse investor needs. These strategies include:
Amplify Bloomberg AI Value Chain ETF (AIVC)
Amplify Bloomberg U.S. Treasury Target High Income ETF (TLTP)
Amplify Small-Mid Cap Equity ETF (SMAP)
Amplify CWP Growth & Income ETF (QDVO)
Amplify Weight Loss Drug & Treatment ETF (THNR)
New and expanded collaborations with industry leaders such as Bloomberg Index Services Limited, Curi RMB Capital, Samsung Asset Management, VettaFi and Capital Wealth Planning powered these launches. These relationships underscore Amplify ETFs’ ability to combine industry expertise with innovative thinking to create relevant, timely investment solutions.
Driven by its talented and growing team, the firm expanded its workforce by 33%, welcoming key additions including Robin Tardy, National Sales Manager, who has strengthened Amplify ETFs’ distribution capabilities and client engagement and Joseph Han, Head of Asia Business Development, who has advanced Amplify ETFs’ presence in Asian markets.
“The growth we’ve achieved wouldn’t be possible without the incredible dedication of our team and the strength of our partnerships,” said William Belden, President of Amplify ETFs. “This milestone is a collective achievement, and we’re enthusiastic about the opportunities ahead.”
Amplify ETFs also earned recognition last year with numerous award nominations from industry publications including With Intelligence and ETF.com, ultimately winning the Digital Assets ETF of the Year award for the Amplify Transformational Data Sharing ETF (BLOK) from With Intelligence for the second consecutive year.
Amplify ETFs remains focused on refining its product offerings and exploring new opportunities to deliver value to investors. Amplify ETFs is committed to innovation, collaboration and impact-driven solutions.
To learn more about Amplify ETFs, visit: http://AmplifyETFs .com .
About Amplify ETFs
Amplify ETFs, sponsored by Amplify Investments, has over $10 billion in assets across its suite of ETFs (as of 01/08/2025). Amplify ETFs deliver expanded investment opportunities for investors seeking growth, income, and risk-managed strategies across a range of actively managed and index-based ETFs.
| Sales Contact: | Media Contacts: |
| Amplify ETFs 855-267-3837 info@amplifyetfs.com | Gregory FCA for Amplify ETFs Kerry Davis 610-228-2098 amplifyetfs@gregoryfca.com |
1 https://etfdb.com/etfs/issuers/#issuer-power-rankings__revenue&sort_name=aum_position&sort_order=asc&page=1
Carefully consider the Fund’s investment objectives, risks, charges, and expenses before investing. This and other information can be found in the Fund’s statutory and summary prospectuses, which may be obtained at AmplifyETFs.com. Read the prospectus carefully before investing.
Investing involves risk, including the possible loss of principal. Shares of any ETF are bought and sold at market price (not NAV), may trade at a discount or premium to NAV and are not individually redeemed from the Fund. Brokerage commissions will reduce returns.
Amplify ETFs are distributed by Foreside Fund Services, LLC.
FAQ**
What factors contributed to the successful launch of the "Amplify Weight Loss Drug & Treatment ETF (THNR)" and how does it fit into Amplify ETFs' overall investment strategy?
How does the performance of the "Amplify Weight Loss Drug & Treatment ETF (THNR)" compare to other funds within Amplify ETFs, particularly in terms of growth and investor interest?
What market trends or investor needs prompted Amplify ETFs to introduce the "Amplify Weight Loss Drug & Treatment ETF (THNR)" in 2024?
Can you share insights on the anticipated impact of the "Amplify Weight Loss Drug & Treatment ETF (THNR)" on the overall growth and asset management strategy of Amplify ETFs moving forward?
**MWN-AI FAQ is based on asking OpenAI questions about SportsMap Tech Acquisition Corp. (NYSE: SMAP).
NASDAQ: SMAP
SMAP Trading
-0.08% G/L:
$24.86 Last:
501 Volume:
$24.88 Open:
